Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

September 01, 2007 (Vol. 27, No. 15)

Process Analytics Remains Elusive Goal

FDA's PAT Has Not Brought About the Changes in Manufacturing That Were Envisioned

  • Over the last five years process monitoring has taken on a new impetus. Inspired by the FDA’s Process Analytic Technology (PAT) initiative, the objective of process monitoring today is nothing short of real-time, in-line analytics. According to the FDA’s vision, real-time process data should help companies design better pharmaceutical ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.